Propanc Commences GLP-Compliant 28-Day Repeat-Dose Toxicity Study
MELBOURNE, AUSTRALIA --(Marketwired - December 22, 2016) - Propanc Health Group Corporation (OTCQB: PPCH) ("Propanc" or "the Company"), an emerging healthcare company focusing on development of new and proprietary treatments for cancer …